Phase 3 Parkinson's Disease Trial, Recruiting (NCT07229664)

Phase 3 Parkinson's Disease Trial, Recruiting NCT07229664 Sponsor: Tanta University Condition: Parkinson's Disease

Printed from Voxsanity (voxsanity.com.au) — NCT07229664 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Parkinsons Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You must be 50 years old or older
Both men and women can take part
Women must have a negative pregnancy test and be using effective birth control
You must have been diagnosed with Parkinson's disease and be currently taking a medication called Levodopa

Who may not be able to join:

You cannot join if your Parkinson's-like symptoms are caused by another condition rather than Parkinson's disease itself
You cannot join if you are currently taking anti-inflammatory medications (such as ibuprofen or similar drugs)
You cannot join if you have been diagnosed with an atypical form of a Parkinson's-related condition (confirm with trial site)
You cannot join if you have previously had a type of brain surgery used to treat Parkinson's disease
You cannot join if you are pregnant or breastfeeding
You cannot join if you have a heart or cardiovascular condition
You cannot join if you have a disorder that affects how your blood clots
You cannot join if you are currently being treated for any active cancer
You cannot join if you have a problem with alcohol or drug addiction
You cannot join if you have a known allergy to any of the medications being studied in this trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

Phase 3: approximately ~65% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07229664

Sponsor: Tanta University

Phase: Phase 3

Status: Recruiting

Condition: Parkinson's Disease

More information: https://clinicaltrials.gov/study/NCT07229664

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You must be 50 years old or older
Both men and women can take part
Women must have a negative pregnancy test and be using effective birth control
You must have been diagnosed with Parkinson's disease and be currently taking a medication called Levodopa

Who may not be able to join:

You cannot join if your Parkinson's-like symptoms are caused by another condition rather than Parkinson's disease itself
You cannot join if you are currently taking anti-inflammatory medications (such as ibuprofen or similar drugs)
You cannot join if you have been diagnosed with an atypical form of a Parkinson's-related condition (confirm with trial site)
You cannot join if you have previously had a type of brain surgery used to treat Parkinson's disease
You cannot join if you are pregnant or breastfeeding
You cannot join if you have a heart or cardiovascular condition
You cannot join if you have a disorder that affects how your blood clots
You cannot join if you are currently being treated for any active cancer
You cannot join if you have a problem with alcohol or drug addiction
You cannot join if you have a known allergy to any of the medications being studied in this trial

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 3

Sponsor

Tanta University

Registry

ClinicalTrials.gov

Start date

10 November 2025

Est. completion

20 November 2026

Where this trial is recruiting

🇪🇬 Egypt

Primary endpoints

Change in The Unified Parkinson's Disease Rating Scale (UPDRS).

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov